Testing effectiveness (Phase 2)Study completedNCT01648140What this trial is testingDose Ranging of GSK2336805 in Combination TherapyWho this might be right forHepatitis C, Chronic GlaxoSmithKline 286
Testing effectiveness (Phase 2)Study completedNCT01057667What this trial is testingRO5024048 in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 1 or 4Who this might be right forHepatitis C, Chronic Hoffmann-La Roche 168
Large-scale testing (Phase 3)Study completedNCT02105701What this trial is testingStudy of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) With or Without Ribavirin for Participants With Hepatitis C Genotype 1, 4, or 6 Infections Who Have Failed Prior Treatment With Pegylated Interferon + Ribavirin (MK-5172-068)Who this might be right forHepatitis C Infection Merck Sharp & Dohme LLC 420
Large-scale testing (Phase 3)Study completedNCT02105688What this trial is testingAn Efficacy and Safety Study of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in the Treatment of Chronic Hepatitis C Virus (HCV) Genotype (GT)1, 4, or 6 Infection in Treatment-Naïve Participants Who Are on Opiate Substitution Therapy (MK-5172-062)Who this might be right forChronic Hepatitis C Merck Sharp & Dohme LLC 301
Testing effectiveness (Phase 2)Study completedNCT01782495What this trial is testingEvaluate Chronic Hepatitis C Infection in Adult Transplant RecipientsWho this might be right forChronic Hepatitis C Infection AbbVie 129
Large-scale testing (Phase 3)WithdrawnNCT01447394What this trial is testingSafety and Efficacy Study of Pegylated Interferon Lambda Versus Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis CWho this might be right forHepatitis C Virus (HCV) Bristol-Myers Squibb
Large-scale testing (Phase 3)Study completedNCT02642432What this trial is testingEvaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated CirrhosisWho this might be right forHepatitis C Virus InfectionChronic Hepatitis CCompensated Cirrhosis AbbVie 146
Testing effectiveness (Phase 2)Study completedNCT01858766What this trial is testingSafety and Efficacy of Sofosbuvir + Velpatasvir With or Without Ribavirin in Treatment-Naive Adults With Chronic HCV InfectionWho this might be right forHepatitis C Gilead Sciences 379
Large-scale testing (Phase 3)Study completedNCT02073656What this trial is testingEfficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infectionWho this might be right forHepatitis C VirusHIV Gilead Sciences 335
Large-scale testing (Phase 3)Ended earlyNCT02504099What this trial is testingEvaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/r With or Without Dasabuvir and With or Without Ribavirin in Chronic Hepatitis C Virus Genotype 1 or 4 Infected Adults With Successfully Treated Early Stage Hepatocellular CarcinomaWho this might be right forChronic Hepatitis C Infection AbbVie 3
Testing effectiveness (Phase 2)Study completedNCT02350569What this trial is testingSafety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation SettingWho this might be right forHepatitis C Virus Infection Gilead Sciences 17
Post-approval studies (Phase 4)UnknownNCT02950870What this trial is testingEfficacy Study to Evaluate the Effect of New Antiviral Drugs on HCV Infection.Who this might be right forChronic Hepatitis, C Virus University of Modena and Reggio Emilia 75
Post-approval studies (Phase 4)Ended earlyNCT02940691What this trial is testingScale-up of Treatment of Hepatitis C Infection Among People Who Inject DrugsWho this might be right forHepatitis C Kirby Institute 32
Not applicableStudy completedNCT02581163What this trial is testingEffectiveness of Paritaprevir/Ritonavir - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in BelgiumWho this might be right forChronic Hepatitis C, Genotype 1 or 4 AbbVie 314
Post-approval studies (Phase 4)Study completedNCT00612755What this trial is testingEfficacy and Safety to Extend Treatment 24 Weeks in co-Infected HIV-HCV Genotype 1 and/or 4Who this might be right forHIV InfectionsHepatitis C Hospital Clinico Universitario San Cecilio 43
Large-scale testing (Phase 3)Study completedNCT02486406What this trial is testingEvaluate Treatment of Hepatitis C Virus Infection in Pediatric SubjectsWho this might be right forChronic Hepatitis C Infection AbbVie 64
Testing effectiveness (Phase 2)UnknownNCT01025297What this trial is testingDose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in HCV Genotype 1 or 4 Patients Resistant to Bitherapy AloneWho this might be right forHepatitis C Cytheris SA 18
Large-scale testing (Phase 3)Study completedNCT01641640What this trial is testingSofosbuvir With Peginterferon Alfa 2a and Ribavirin for 12 Weeks in Treatment-Naive Subjects With Chronic Genotype 1, 4, 5, or 6 HCV InfectionWho this might be right forChronic Hepatitis C Gilead Sciences 328
Testing effectiveness (Phase 2)Study completedNCT02262728What this trial is testingAn Efficacy, Safety and Pharmacokinetics Study of Simeprevir, Daclatasvir and Sofosbuvir in Participants With Chronic Hepatitis C Virus Genotype 1 or 4 Infection and Decompensated Liver DiseaseWho this might be right forHepatitis C, Chronic Janssen Research & Development, LLC 40
Testing effectiveness (Phase 2)Study completedNCT00869661What this trial is testingRO5024048 in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C, Genotype 1 or 4Who this might be right forHepatitis C, Chronic Hoffmann-La Roche 413